165 related articles for article (PubMed ID: 28713005)
1. Steroid 5-alpha-reductase type 2 (SRD5A2) gene V89L polymorphism and hypospadias risk: A meta-analysis.
Zhang K; Li Y; Mao Y; Ma M
J Pediatr Urol; 2017 Dec; 13(6):630.e1-630.e9. PubMed ID: 28713005
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of 17 β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias.
Sata F; Kurahashi N; Ban S; Moriya K; Tanaka KD; Ishizuka M; Nakao H; Yahata Y; Imai H; Kakizaki H; Nonomura K; Kishi R
J Sex Med; 2010 Aug; 7(8):2729-38. PubMed ID: 20059664
[TBL] [Abstract][Full Text] [Related]
3. Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children.
Samtani R; Bajpai M; Vashisht K; Ghosh PK; Saraswathy KN
J Urol; 2011 Jun; 185(6):2334-9. PubMed ID: 21511288
[TBL] [Abstract][Full Text] [Related]
4. The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadias.
Thai HT; Kalbasi M; Lagerstedt K; Frisén L; Kockum I; Nordenskjöld A
J Clin Endocrinol Metab; 2005 Dec; 90(12):6695-8. PubMed ID: 16174723
[TBL] [Abstract][Full Text] [Related]
5. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.
Rahimi M; Ghanbari M; Fazeli Z; Rouzrokh M; Omrani S; Mirfakhraie R; Omrani MD
J Endocrinol Invest; 2017 Apr; 40(4):391-396. PubMed ID: 27848231
[TBL] [Abstract][Full Text] [Related]
6. Association between
Sun L; Zhou M; Liu T
Pharmazie; 2019 Feb; 74(2):125-128. PubMed ID: 30782264
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
[TBL] [Abstract][Full Text] [Related]
8. Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis.
Zhang D; Li Q; Qu HC; Yu T; Liu YR
Genet Mol Res; 2015 Aug; 14(3):9004-12. PubMed ID: 26345832
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
10. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
Wang C; Tao W; Chen Q; Hu H; Wen XY; Han R
Prostate; 2010 Feb; 70(2):170-8. PubMed ID: 19760631
[TBL] [Abstract][Full Text] [Related]
11. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.
Li Q; Zhu Y; He J; Wang M; Zhu M; Shi T; Qiu L; Ye D; Wei Q
Mol Biol Rep; 2013 May; 40(5):3597-608. PubMed ID: 23277398
[TBL] [Abstract][Full Text] [Related]
12. Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.
Li J; Coates RJ; Gwinn M; Khoury MJ
Am J Epidemiol; 2010 Jan; 171(1):1-13. PubMed ID: 19914946
[TBL] [Abstract][Full Text] [Related]
13. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Torkko KC; van Bokhoven A; Mai P; Beuten J; Balic I; Byers TE; Hokanson JE; Norris JM; Barón AE; Lucia MS; Thompson IM; Leach RJ
Clin Cancer Res; 2008 May; 14(10):3223-9. PubMed ID: 18483391
[TBL] [Abstract][Full Text] [Related]
14. Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications.
Fang C; Guo ZQ; Chen XY; Liu TZ; Zeng XT; Wang XH
Medicine (Baltimore); 2017 May; 96(19):e6791. PubMed ID: 28489754
[TBL] [Abstract][Full Text] [Related]
15. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation?
van der Zanden LF; van Rooij IA; Feitz WF; Vermeulen SH; Kiemeney LA; Knoers NV; Roeleveld N; Franke B
J Clin Endocrinol Metab; 2010 May; 95(5):2384-90. PubMed ID: 20215396
[TBL] [Abstract][Full Text] [Related]
16. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
[TBL] [Abstract][Full Text] [Related]
17. Association between
Zeng XT; Su XJ; Li S; Weng H; Liu TZ; Wang XH
Front Physiol; 2017; 8():688. PubMed ID: 28955247
[No Abstract] [Full Text] [Related]
18. Lack of genetic associations between PPAR-γ gene rs1801282 polymorphism and Alzheimer's disease in general population: a meta-analysis.
Wu Y; Wu Q; Zhang H; Chen C; Chen G; Yang H; Qin D; Fu H
Gene; 2015 Jun; 563(2):120-4. PubMed ID: 25770052
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias.
Wang R; Dong Z; Wang W; Xiao Y; Ni J; Wang D
J Pediatr Endocrinol Metab; 2013; 26(9-10):887-93. PubMed ID: 23729601
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
